Amanta Healthcare Limited has provided a clarification to stock exchanges regarding the completion of a share acquisition transaction by promoter Shri Bhavesh Patel. The company confirmed that the remaining portion of shares from an earlier acquisition has been successfully credited to the promoter's demat account.

Transaction Completion Details

The company clarified that 15,500 equity shares purchased on March 30, 2026, were credited to Shri Bhavesh Patel's demat account on April 17, 2026. This represents the completion of a larger transaction involving 28,800 equity shares, for which the company had provided initial intimation to stock exchanges on April 1, 2026.

The clarification follows an earlier communication dated April 18, 2026, regarding the credit of 13,300 equity shares to the same promoter's demat account, indicating that the transaction was completed in two separate tranches.

Revised Shareholding Position

Following the complete transaction, the company has provided updated details of the promoter's shareholding position:

The acquisition represents a marginal increase of 0.04% in the promoter's voting capital, bringing the total shareholding to 16.29% from the previous 16.25%.

Regulatory Compliance

Amanta Healthcare has requested both BSE Limited and National Stock Exchange of India Limited to take this clarification on record and replace the earlier intimation with the revised information. This ensures accurate reflection of the promoter's shareholding position in the exchange records.

The company's communication, signed by Company Secretary and Compliance Officer Nikhita Dinodia, demonstrates adherence to regulatory disclosure requirements for promoter share transactions. The clarification provides transparency regarding the timing and completion of the share credit process, ensuring all stakeholders have accurate information about the promoter's current shareholding status.

Amanta Healthcare Limited has announced the resignation of a senior management personnel, informing stock exchanges about the departure of Shri Vimal Shrimali from his position as Assistant Vice President – HR & ADMIN. The company made this disclosure in compliance with regulatory requirements under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Resignation Details

The resignation becomes effective from the close of business hours on April 16, 2026. According to the company's regulatory filing, Shrimali tendered his resignation citing personal reasons for his departure from the senior management position.

Regulatory Compliance

Amanta Healthcare Limited notified both BSE Limited and National Stock Exchange of India Limited about this senior management change as mandated under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. The company provided all required details as per Schedule III of the regulations.

In his resignation letter dated April 10, 2026, Shrimali mentioned his desire to resign from his present role for future advancement and better opportunities. He expressed his availability for any transition handover processes to ensure smooth operations.

Company Acknowledgment

The company has formally acknowledged Shrimali's resignation and confirmed his relief from duties effective from the specified date. Amanta Healthcare Limited's Company Secretary and Compliance Officer, Nikhita Dinodia, signed the regulatory disclosure documents submitted to the stock exchanges.

The resignation represents a change in the senior management structure of the healthcare company, which maintains its registered and corporate office at Shaligram Corporates, Ambli, Ahmedabad, Gujarat.